Consuming this plant doesn't make you a bad person. Good, smart, and kind people use #cannabis. 🌱 Stereotypes and stigma negatively affect patients across the globe. Patients should be allowed to consume their medication in peace, free of judgment and anxiety. #MedicalCannabis #Stigma #CannabisCommunity
GROW® Group PLC
Biotechnology
Liverpool Street, England 2,980 followers
Unlocking the potential of cannabis medicines for those who need it.
About us
Unlocking the potential of cannabis medicines for those who need it. Our Market Access Team launches medical cannabis producers' businesses into new markets to create long-term value for them. Our R&D Team creates new technologies for medical cannabis producers to create better, cost-effective, accessible medicines for patients. By combining our strengths as scientists, technologists, and commercial strategists, we create game-changing Intellectual Property that will transform the fastest growing industry in the world, medical cannabis. Find all our links at: https://growgroup.komi.io
- Website
-
https://growgroupplc.com
External link for GROW® Group PLC
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Liverpool Street, England
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Cannabis Biotech, Medical Cannabis, Research & Development, Technology, Biotech, Market Access, Medical Affairs, and Accessibility
Locations
-
Primary
Get directions
29 Throgmorton Street
GROW Group Office
Liverpool Street, England EC2N 2AT, GB
-
Get directions
Calgary, Alberta T2P 1J9, CA
Employees at GROW® Group PLC
-
Pierre van Weperen
CEO Grow Pharma | Grow Group UK | Chair of the Board at Dutch National MS Society | Member of the Exec of the CIC
-
Chris Cordier
Head of Research & Development at GROW® Group PLC
-
Hannah Nommé
Community & Investor Relations Lead at Grow Group Plc
-
Benjamin Langley
Founder & Chief Executive Officer at Grow Group PLC
Updates
-
GROW® Group PLC reposted this
Exciting times at the Pain and Research Meeting in Birmingham! Pain-Train hosted a Medical Cannabis #debate with audience participation 🩺🌱 The debate on medical cannabis was fascinating, with healthcare professionals showing great receptiveness. We clarified the crucial differences between medical cannabis and high-street CBD and emphasized that while medical cannabis is unlicensed, it's certainly not unregulated. It's wonderful to see such engagement and interest in advancing patient care! Stigma amongst UK Healthcare Professionals towards medical cannabis is reducing. #PainAndResearch #MedicalCannabis #HealthcareProfessionals #Cannabis #PatientCare #ChronicPain #PainTrain #Birmingham University of Birmingham Pierre van Weperen Anup Shah GROW® Group PLC
-
-
It's brilliant to see more excellent partnerships being fostered in this space. We're committed to platforming the best producers, clinics, and organisations, to help the UK Medical Cannabis industry grow to the size it should be. Check out SOMAÍ Pharmaceuticals' incredible work on their page, and through their website: https://somaipharma.eu/ #medicalcannabis #portugal #cannabis #excellence #team
SOMAÍ Pharmaceuticals Medicines are now available in the UK! 🇬🇧🌱 The first Somai oils and flowers launched this week. SOMAÍ Pharmaceuticals is a leading EU-GMP European pharmaceutical and biotech company with a global distribution footprint for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceuticals portfolio. SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. SOMAÍ recently announced partnerships with GROW® Pharma for UK distribution of one of the most differentiated cannabinoid-containing product portfolios in the market, with the first product line launching in May 2024: https://lnkd.in/g9vZGScJ Find out more about SOMAÍ at https://somaipharma.eu/ #somaipharmaceuticals #somaipharma #ukbusiness #portugal #cannabiscultivation #cannabisindustry #industrynews #uknews #medicalcannabis #cannabiscommunity Pierre van Weperen Michael Sassano
-
-
GROW® Group PLC reposted this
Exciting Collaboration Update: Grow Pharma, Avextra and Canopy Growth Corporation Collaborate to Serve UK Patients! We're excited to share some fantastic news! Grow Pharma and Avextra are expanding their UK collaboration to include Canopy Growth, aiming to further enhance patient access to premium medical cannabis products across the UK. The extended collaboration now enables Grow Pharma to purchase and sell the highly sought-after Canopy Growth flower range, alongside Grow Pharma’s existing offerings. This means more options and enhanced accessibility, ensuring that patients and doctors alike can benefit from top-quality products. Pierre van Weperen, CEO of Grow Pharma, remarked, "We know that the Canopy flower range has been out of reach for many patients. That is simply not good enough. With this new collaboration, Grow Pharma can offer the Canopy Growth flower range and we are confident patients will appreciate the quality and value these products bring. We are of course very pleased that Canopy recognises our strong UK distribution and services track record." Tara Rozalowsky, Chief Growth Officer and President, International, Canopy Growth, commented, "We are excited to expand our UK offerings in collaboration with Grow Pharma and Avextra by introducing three globally top-performing flower SKUs from our EU-GMP certified cultivation facility in Canada. This reflects Canopy’s steadfast commitment to providing quality and variety for patients who will now have access to Canopy Medical Kush Mints, Tiger Cake, and OG Deluxe flower products. Having played an active role in delivering medical cannabis for patients in the UK since 2019, we are proud to take this next step forward to provide exciting new products for medical cannabis patients across the UK." #GrowPharma #Avextra #CanopyGrowth #MedicalCannabis #Partnership #UKHealthcare #PatientCare #IPSPharma
-
GROW® Group PLC reposted this
Make sure to catch our CEO Pierre van Weperen amongst this impressive lineup at Cannabis Europa this week! Our team are excited for a few days of compelling talks, fresh ideas, and meeting new faces. If you'd like to meet with our team, please contact hello@growgroupplc.com 🌱 #cannabis #cannabisindustry #europeancannabis #medicalcannabis #talk #conference
Cannabis in the UK: Sky's the limit - the growth of Europe's 2nd biggest medical market 🗣 ◦ Jonathan Hodgson - MD UK & Nordics, Curaleaf International ◦ Anne Katrin Schlag - CEO, Drug Science ◦ Pierre van Weperen - CEO GROW® Pharma , GROW® Group PLC ◦ Gregory Dobbin - CEO, 4C LABS ◦ Robin Emerson - Managing Director, Jorja Healthcare Group The medical cannabis sector in the United Kingdom is beggining to show signs of real tangible growth. Per the Prohibition Partners European Cannabis Report, patient numbers are expected to hit 62,000 by the end of 2024. What is driving this exponential growth and what realistic goals should be set over the next 3-5 years? Are we about to see significant change in a country which has all the tools to become a huge medical player? We speak to a panel of UK leaders to discuss how the industry can push UK cannabis to the next level, finally realising its promise. 🎟️👉 https://lnkd.in/ejdEitgN #CE2024
-
-
GROW® Group PLC reposted this
We're thrilled to have attended the The British Pain Society Conference this week! 🌱 It was incredible to see so many healthcare professionals engaging in meaningful conversations about the potential benefits of medical cannabis. Together, we’re paving the way for a brighter, more informed future in pain management. #GrowPharma #BritishPainSociety #MedicalCannabis #PainManagement #HealthcareInnovation Anup Shah Jenna Kilgas
-
-
GROW® Group PLC reposted this
🚀 GROW war auch dieses Jahr auf dem Medicinal Cannabis Congress in Berlin vertreten 💙 Neben vielen neuen Kontakten haben wir uns auch sehr über das Wiedersehen mit alten Bekannten gefreut 🔬 Unser Highlight: Die Vorstellung unserer neuen Studie CAMFIT, durch Dr. med. Dipl.-Chem. Konrad F. Cimander, stieß auf großes Interesse in der medizinischen Fachwelt ✅ GROW setzt sich weiterhin für Bildung und Wissenstransfer ein, um die Patientenversorgung kontinuierlich zu verbessern - Weil jeder Patient zählt! #DMCG #MedizinalCannabis #Weiterbildung Susan Bailey Nosbuesch Vanessa Mühlhäuser
-
-
Looking to meet our team this summer? ☀️ Drop us an email on hello@growgroupplc.com to arrange a meeting, or stop by any of these events and chat with our team! • 14-16th June- GROW® Deutschland GmbH Stand at Mary Jane Berlin • 20th June- Integro Medical Clinics Glasgow Patient Conference (GROW speakers) • 25-26th June- Sponsorship and stand at Cannabis Europa • 10th August- Sponsorship of the Patient Lounge at the Hanfparade (Hemp Parade) in Berlin #summer #summerevents #cannabisevents #cannabiscommunity #cannabisindustry #germancannabis #medicalcannabis #investorrelations #hanfparade
-
-
GROW® Group PLC reposted this
Episode 7 of "Grow Conversations: Your Window Into the World of Medical Cannabis" is out now!🎉 Featuring International Cannabis Powerhouse SOMAÍ Pharmaceuticals' CEO, Michael Sassano. In this podcast we discussed a range of topics including: • Michael's background setting up cultivation facilities in the US • The SOMAÍ product pipeline • Medical vs recreational - the CEO's perspective • Developments in German and US legislation • The nuanced differences between different medical cannabis markets internationally ...and much much more. SOMAÍ will be launching in the UK very shortly! Head to our YouTube or any streaming platform to listen. Happy Friday 🌱 #medicalcannabis #cannabiscommunity #portugal #podcast #ukpodcast #podcastclips #healthpodcast https://lnkd.in/e4XhUjGv
-
We are excited to announce our sponsorship of Prohibition Partners' latest European cannabis report! Partnering with them allows us to shine a light on the strength of the European cannabis industry, advancing its legitimacy and ensuring more people gain access to medical cannabis. Make sure to read Prohibition Partners' interview with our leadership team, for an in-depth look into how GROW operates. We're committed to fostering growth, innovation, and accessibility in this dynamic sector. #ProhibitionPartners #cannabisindustry #cannabisreport #industryreport #partnership #europeancannabis
The 9th Edition of the longest-standing annual report dedicated to Europe's evolving and dynamic legal cannabis market is now available. The European Cannabis Report: 9th Edition, endorsed by headline partner, Curaleaf Laboratories, offers the most up-to-date insights and analysis on the evolution of key cannabis markets across Europe, including: Germany, the UK, Switzerland, the Netherlands and the Czech Republic. The report covers: 🏥 Medical: The current rate of progress in medical cannabis in Europe is significant, from both a regulatory and a market growth perspective. 🌿 Adult-Use: Adult-use cannabis in Europe has seen significant strides made over the past year, with the legal landscape incrementally shifting towards legalisation, most notably in Germany. 🧴 CBD: The European CBD industry has experienced a long period of regulatory stagnation, with Novel Food applications at the EU and UK level seemingly at a standstill. 📈 Market Size: Forecasts for 30 European countries, broken down by year (2024-2028) and country. Patient population forecasts are also provided as part of the Medical Market Sizing Data & Analysis package. There is a free-to-download version of the report available (excludes market sizing analysis). For market sizing data and analysis, please see the paid-for packages available 👉 https://lnkd.in/efCdyfrS Massive thanks to our sponsors: Curaleaf Laboratories, Tikun Olam Europe, CANNAVIGIA, Fluence, IMCI Pharmaceuticals, Linnea SA PHCANN INTERNATIONAL, GROW® Pharma & MJBiz.